Pricing
  1. JP-listed companies
  2. AFC-HD AMS Life Science Co.,Ltd.
  3. Financials
  4. Net income margin (%)

AFC-HD AMS Life Science Co.,Ltd.【JP:2927】

Market cap
¥12.7B
P/E ratio
8.5x
AFC-HD Amus Life Science develops and sells health foods, cosmetics, and pharmaceuticals to consumers and medical institutions across multiple channels.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
Aug 31, 20254.5+8.44%
Aug 31, 20244.1-4.12%
Aug 31, 20234.3+34.90%
Aug 31, 20223.2-52.03%
Aug 31, 20216.7+56.31%
Aug 31, 20204.3-11.24%
Aug 31, 20194.8+3.34%
Aug 31, 20184.7+51.58%
Aug 31, 20173.1-8.05%
Aug 31, 20163.3-20.34%
Aug 31, 20154.2+103.77%
Aug 31, 20142.1-48.26%
Aug 31, 20134+3.59%
Aug 31, 20123.8+14.99%
Aug 31, 20113.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)